{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:44:48Z","timestamp":1794887088642,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.seizure.2025.11.011","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:18:24Z","timestamp":1762730304000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Brivaracetam vs. Oxcarbazepine in childhood self-limited focal epilepsies (BRAVO-SeLFEs): A pilot randomized controlled trial"],"prefix":"10.1016","volume":"134","author":[{"given":"Fathima","family":"Fasin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-8917","authenticated-orcid":false,"given":"Ankit Kumar","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8185-2076","authenticated-orcid":false,"given":"Saurabh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-0736","authenticated-orcid":false,"given":"Lokesh","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-9619","authenticated-orcid":false,"given":"Sujatha","family":"Manjunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-7376","authenticated-orcid":false,"given":"Tanu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5973-328X","authenticated-orcid":false,"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0507-2596","authenticated-orcid":false,"given":"Ashwini","family":"Chityala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-6909","authenticated-orcid":false,"given":"Jagdish Prasad","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3093","authenticated-orcid":false,"given":"Naresh","family":"Nebhinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-3233","authenticated-orcid":false,"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2025.11.011_bib0001","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on nosology and Definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2025.11.011_bib0002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.pjnns.2018.08.010","article-title":"Benign epilepsy with centrotemporal spikes \u2013 Current concepts of diagnosis and treatment","volume":"52","author":"Dry\u017ca\u0142owski","year":"2018","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.seizure.2025.11.011_bib0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpn.2023.08.004","article-title":"A reappraisal of interictal EEG characteristics in self-limited epilepsy with autonomic seizures, formerly known as Panayiotopoulos syndrome or early-onset benign occipital epilepsy","volume":"47","author":"Oguni","year":"2023","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2025.11.011_bib0004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/09297049.2022.2028754","article-title":"Neuropsychological and behavioral profiles of self-limited epileptic syndromes of childhood: a cross-syndrome comparison","volume":"28","author":"Baggio","year":"2022","journal-title":"Child Neuropsychol"},{"key":"10.1016\/j.seizure.2025.11.011_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1092244","article-title":"Self-limited childhood epilepsies are disorders of the perisylvian communication system, carrying the risk of progress to epileptic encephalopathies-critical review","volume":"14","author":"Hal\u00e1sz","year":"2023","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2025.11.011_bib0006","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.yebeh.2006.04.022","article-title":"Efficacy, safety, and tolerability of oxcarbazepine monotherapy","volume":"9","author":"Martinez","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2025.11.011_bib0007","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.11.011_bib0008","article-title":"Overnight switch from levetiracetam to brivaracetam. Safety and tolerability","volume":"16","author":"Abraira","year":"2021","journal-title":"Epilepsy Behav Rep"},{"issue":"8","key":"10.1016\/j.seizure.2025.11.011_bib0009","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2025.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s13760-021-01613-5","article-title":"Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes","volume":"121","author":"Suo","year":"2021","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.seizure.2025.11.011_bib0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/jrpp.JRPP_20_53","article-title":"A comparative study on the efficacy of Levetiracetam and Carbamazepine in the treatment of rolandic seizures in children: an open-label randomized controlled trial","volume":"9","author":"Ahadi","year":"2020","journal-title":"J Res Pharm Pract"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2025.11.011_bib0012","first-page":"57","article-title":"Epilepsias focales autolimitadas de la infancia [Self-limited focal epilepsies of childhood]","volume":"83","author":"Quito-Betancourt","year":"2023","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.seizure.2025.11.011_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/epd2.20045","article-title":"Focal epilepsies: Update on diagnosis and classification","volume":"25","author":"Nascimento","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2025.11.011_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpn.2023.08.004","article-title":"A reappraisal of interictal EEG characteristics in self-limited epilepsy with autonomic seizures, formerly known as Panayiotopoulos syndrome or early-onset benign occipital epilepsy","volume":"47","author":"Oguni","year":"2023","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2025.11.011_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/088307380201700104","article-title":"Benign childhood epilepsy with centrotemporal spikes: clinical characteristics and identification of patients at risk for multiple seizures","volume":"17","author":"Kramer","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2025.11.011_bib0016","article-title":"Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2024","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.seizure.2025.11.011_bib0018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.braindev.2006.09.008","article-title":"Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial","volume":"29","author":"Coppola","year":"2007","journal-title":"Brain Dev"},{"issue":"4","key":"10.1016\/j.seizure.2025.11.011_bib0017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2025.11.011_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14581\/jer.25005","article-title":"Brivaracetam: pharmacology, clinical efficacy, and safety in epilepsy","volume":"15","author":"Hwang","year":"2025","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.seizure.2025.11.011_bib0020","doi-asserted-by":"crossref","first-page":"107939","DOI":"10.1016\/j.yebeh.2021.107939","article-title":"Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review","volume":"118","author":"Steinhoff","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"Pt A","key":"10.1016\/j.seizure.2025.11.011_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.09.005","article-title":"An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam","volume":"52","author":"Yates","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2025.11.011_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14581\/jer.17001","article-title":"The clinical spectrum of benign epilepsy with centro-temporal spikes: a challenge in categorization and predictability","volume":"7","author":"Lee","year":"2017","journal-title":"J Epilepsy Res"},{"issue":"6","key":"10.1016\/j.seizure.2025.11.011_bib0023","first-page":"1885","article-title":"Electrical status epilepticus during sleep (ESES) in benign childhood epilepsy with Centrotemporal spikes (BCECTS): insights into predictive factors, and clinical and EEG outcomes","volume":"26","author":"Ucar","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.seizure.2025.11.011_bib0024","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/15500594231182758","article-title":"The prevalence and risk factors of electrical status epilepticus during slow-wave sleep in self-limited epilepsy with centrotemporal spikes","volume":"55","author":"Lu","year":"2024","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.seizure.2025.11.011_bib0025","first-page":"1","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.seizure.2025.11.011_bib0027","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s12325-024-02876-z","article-title":"Narrative review of Brivaracetam: preclinical profile and clinical benefits in the treatment of patients with epilepsy","volume":"41","author":"Klein","year":"2024","journal-title":"Adv Ther"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:48:45Z","timestamp":1768348125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125003139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S1059131125003139"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.11.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brivaracetam vs. Oxcarbazepine in childhood self-limited focal epilepsies (BRAVO-SeLFEs): A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}